Mesothelioma.com - Helping Mesothelioma Patients Since 1996 call

Mesothelioma Pleurocentesis

Katy Moncivais, PhD
Reviewer: Annette Charlevois
Last Updated: 6/25/2025

Mesothelioma pleurocentesis is a minimally invasive procedure that removes fluid buildup in the lungs. The procedure is also known as thoracentesis. It can alleviate some pleural mesothelioma symptoms, such as shortness of breath. Pleurocentesis may be performed as an outpatient procedure.

Learn More About Pleurocentesis in Our Free Mesothelioma Guide
Pleurocentesis for Mesothelioma

A diagram showing how the pleurocentesis procedure removes excess fluid from between the two layers of the pleura

What Is Pleurocentesis?

Pleurocentesis is commonly known as thoracentesis. Pleurocentesis is a minimally invasive procedure that removes fluid from the pleural space. The pleural space (pleural cavity) is the space between the two layers of the pleura. The pleura is the double-layered membrane surrounding the lungs.

The pleural space typically holds a small amount of pleural fluid. Pleural fluid allows the lungs to expand and contract smoothly. However, disease or illness can increase the amount of pleural fluid, creating a condition called pleural effusion.

Pleural effusion can compress the lung, causing uncomfortable symptoms. Pleurocentesis drains the excess fluid responsible for causing such symptoms.

How Does Pleurocentesis Treat Mesothelioma Symptoms?

Pleurocentesis treats one common mesothelioma symptom: pleural effusion.

Asbestos exposure causes malignant pleural mesothelioma (MPM). MPM can cause excessive fluid to collect in the pleural space. This fluid may take up space normally occupied by the lung. This can make it difficult for the lung to expand and contract. Mesothelioma patients with pleural effusion often experience difficulty breathing as a result.

Pleurocentesis addresses this issue by removing the excess fluid in the pleural space. The procedure provides temporary relief of pleural effusion symptoms. However, pleural effusion may recur in some patients.

In cases of recurrent pleural effusion, mesothelioma doctors may recommend pleurodesis. Pleurodesis collapses the pleural space in an effort to prevent fluid buildup.

The Pleurocentesis Procedure

Doctors may administer pleurocentesis as an outpatient or inpatient procedure. The choice between outpatient and inpatient depends on the individual patient and their unique situation.

Pleurocentesis usually takes 10 to 15 minutes. However, the procedure may take longer if there is a lot of fluid in the pleural space. The amount of fluid removed during pleurocentesis varies from patient to patient. In some cases, the procedure may remove three liters of fluid or more from the pleural space.

The procedure may include the following steps:

  1. The patient may require oxygen during the procedure. If so, the patient may receive a nasal tube or face mask for oxygen.
  2. A health care provider will identify the area of the skin where the needle will go.
  3. A provider will clean the skin with an antimicrobial fluid.
  4. A health care provider will apply a sterile numbing medicine to the skin.
  5. The treatment team will wait for the skin to become numb. This means the pleurocentesis should not cause much, if any, pain.
  6. A health care provider will use a hollow needle to access the pleural space. The patient may feel some pressure where the needle enters the skin.
  7. Depending on the amount of fluid, the provider will use a syringe or a tube to drain the fluid.
  8. If necessary, a health care provider will replace the needle with a flexible tube (catheter) that stays in place. This will allow fluid to drain for a day or two.
  9. Once a sufficient amount of fluid has drained, a health care provider will remove the needle and/or tube. This fluid may be sent for biomarker analysis.
  10. The physician may also order imaging tests such as a chest X-ray or CT scan. These tests will check for complications from the procedure.

Pleurocentesis Recovery

During and directly following the procedure, the care team will monitor the patient’s vitals. This includes blood pressure, heart rate and breathing. Once a doctor clears them to leave, the patient can return home.

The patient will need to have someone drive them home. Depending on the patient’s occupation, they may also need to take a day or two off from work to recover.

The treating physician will provide guidelines regarding physical activity limitations after pleurocentesis. The care team will also provide a list of potentially serious side effects. These may include a high fever, chest pain and vomiting.

Pleurocentesis patients should contact their doctor with any concerns in the weeks immediately after the procedure.

Pleurocentesis Side Effects and Risks

According to experts, pleurocentesis is generally safe. It is uncommon for major complications to arise due to pleurocentesis. However, some patients do experience side effects during or after surgery.

Possible Side Effects of Pleurocentesis
  • Air in the pleural space
  • Bleeding
  • Collapsed lung (pneumothorax)
  • Coughing
  • Fainting
  • Infection
  • Pain or discomfort
  • Rarely, cancer seeding/metastasis (cancer cells spreading elsewhere along the incision site)
  • Rarely, injury to the liver or spleen

According to medical literature, some patient factors may increase the risk of pleurocentesis complications. For example, one study found underweight patients had a higher risk of a collapsed lung (pneumothorax). Underweight means body mass index (BMI) lower than 18 kg/m2. This is roughly equivalent to a weight less than 104 pounds for a 5’4″ person.

In another study, procedures requiring more than one needle stick had a higher rate of pneumothorax.

Physician factors may also affect the risk of pleurocentesis side effects. Using ultrasound to guide needle placement has been associated with fewer side effects. In one pleurocentesis study, ultrasound reduced the risk of pneumothorax by 19%. Ultrasound also reduced the average cost of treatment and the length of hospital stays.

Learn About Financial Assistance Available for Treatment Costs Learn more with our free information packet Get Help Now

Benefits and Advantages of Pleurocentesis

Pleurocentesis can provide several benefits, including symptom relief. The following benefits have been reported for pleurocentesis:

  • Doctors can administer pleurocentesis as a palliative treatment.
  • Patients can undergo repeat pleurocentesis if necessary.
  • Patients experience reduced feelings of breathlessness (dyspnea) after pleurocentesis.
  • Pleurocentesis improves mental and physical quality of life for pleural effusion patients.

In one study, 30% of pleurocentesis patients had recurrent pleural effusion within 15 days of treatment. Thus, the repeatability of pleurocentesis is important.

After pleurocentesis, patients may also consider additional treatment options. For instance, pleural mesothelioma patients with operable disease may undergo a pleurectomy/decortication (P/D). This surgical treatment aims to remove cancer cells by removing the pleura. In doing so, P/D may also prevent recurrence of pleural effusion.

Pleurocentesis Eligibility

Eligibility for pleurocentesis depends on several factors, including the patient’s overall health. It may be suitable for most pleural mesothelioma patients.

However, certain factors may make pleurocentesis inappropriate for an individual. These factors include:

  • Active infection
  • Certain bleeding conditions
  • Unusual chest wall anatomy

A patient’s eligibility for pleurocentesis is best determined by a mesothelioma specialist. A mesothelioma doctor can explain an individual’s eligibility for pleurocentesis and other treatment options. They can develop a personalized treatment plan for the patient’s unique needs.

Sources
  1. American Thoracic Society. Management of malignant pleural effusions. American Journal of Respiratory and Critical Care Medicine. November 2000;162(5):1987-2001. doi: 10.1164/ajrccm.162.5.ats8-00

  2. American Thoracic Society. Thoracentesis. ATS Patient Education Series. 2016.

  3. Argento AC, Murphy TE, et al. Patient-Centered Outcomes Following Thoracentesis. Pleura. January-December 2015;2:2373997515600404. doi: 10.1177/2373997515600404

  4. Ault MJ, Rosen BT, et al. Thoracentesis outcomes: a 12-year experience. Thorax. February 2015;70(2):127-32. doi: 10.1136/thoraxjnl-2014-206114

  5. Brauner M. Thoracentesis. Medscape. December 2013.

  6. Cantey EP, Walter JM, et al. Complications of thoracentesis: incidence, risk factors, and strategies for prevention. Current Opinion in Pulmonary Medicine. July 2016;22(4):378-85. doi: 10.1097/MCP.0000000000000285

  7. Chandrasekhar A and Garrity E. Thoracentesis and Fluid analysis. Loyola University Medical Education Network. Updated January 2006.

  8. Feller-Kopman D, Berkowitz D, et al. Large-volume thoracentesis and the risk of reexpansion pulmonary edema. Annals of Thoracic Surgery. November 2007;84(5):1656-61. doi: 10.1016/j.athoracsur.2007.06.038

  9. Fox Chase Cancer Center. Pleural Disease. December 2013.

  10. Grosu HB, Molina S, et al. Risk factors for pleural effusion recurrence in patients with malignancy. Respirology. January 2019;24(1):76-82. doi: 10.1111/resp.13362

  11. Johns Hopkins Medicine. Thoracentesis. Health Library.

  12. Kaiser Permanente. Thoracentesis: What to Expect at Home Your Recovery. October 2020.

  13. Karkhanis VS and Joshi JM. Pleural effusion: diagnosis, treatment, and management. Open Access Emergency Medicine. June 2012;4:31-52. doi: 10.2147/OAEM.S29942

  14. Lechtzin N. How to Do Thoracentesis. Merck Manual. Updated October 2016.

  15. MedlinePlus. Thoracentesis. National Institutes of Health. August 2012.

  16. Mohammed I, Maddirala S, et al. Evaluating Clinical Predictors of Complications of Thoracentesis. Chest Journal. October 2010;138(4)suppl:348A. doi: 10.1378/chest.10230

  17. Muduly D, Deo S, et al. An update in the management of malignant pleural effusion. Indian Journal of Palliative Care. May-August 2011;17(2):98-103. doi: 10.4103/0973-1075.84529

  18. National Heart, Lung, and Blood Institute. Lung Disease Treatments.

  19. Shyamala K, Girish H, et al. Risk of tumor cell seeding through biopsy and aspiration cytology. Journal of International Society of Preventive and Community Dentistry. January-April 2014;4(1):5–11. doi: 10.4103/2231-0762.129446

  20. Sivakumar P, Saigal A, et al. Quality of life after interventions for malignant pleural effusions: a systematic review. BMJ Supportive and Palliative Care. March 2020;10(1):45-54. doi: 10.1136/bmjspcare-2018-001610

  21. van Zandwijk N, Clarke C, et al. Guidelines for the diagnosis and treatment of malignant pleural mesothelioma. Journal of Thoracic Disease. December 2013;5(6):E254-E307. doi: 10.3978/j.issn.2072-1439.2013.11.28

Free Mesothelioma Treatment Guide

Free Mesothelioma Treatment Guide
Your Free Guide will be delivered to you within 24 hours.

What You Will Learn About

  • Mesothelioma Cancer Centers
  • Top Mesothelioma Doctors
  • Current Mesothelioma Treatments
  • Palliative Care Options
  • Mesothelioma Caregiver Information
Request a Free 2026 Mesothelioma Guide
Katy Moncivais, PhD, Medical Editor at Mesothelioma.com
Written by Katy Moncivais, PhD Medical Editor
Annette Charlevois
Reviewed by Annette Charlevois Patient Support Coordinator
Free mesothelioma guide for patient and and their loved ones Free Mesothelioma Guide